The World Health Organization (WHO) has issued a warning about a batch of contaminated common cold syrup sold in Iraq. The syrup, branded Cold Out, was manufactured by Fourrts (India) Laboratories for Dabilife Pharma. WHO reported that the syrup contained higher than acceptable levels of contaminants diethylene glycol and ethylene glycol. The batch had 0.25% diethylene glycol and 2.1% ethylene glycol, exceeding the acceptable safety limit of 0.10%. The manufacturer and marketer have not provided guarantees of safety and quality for the product. The companies have not yet responded to requests for comment. This is the latest in a series of warnings by WHO about substandard medicines from India. Several cough syrups, including those made in India, have been linked to deaths in other countries, such as Gambia and Uzbekistan. Marion Biotech had its manufacturing license canceled and Riemann Labs faced violations after their cough syrups were linked to deaths in Cameroon. Maiden Pharmaceuticals, the company involved in Gambia, denied responsibility for the deaths, and Indian government laboratory tests found no toxins in their drugs.
Indian-Made Cold Syrup Sold in Iraq Raises Concerns of Contamination, Warns WHO
Denial of responsibility! Swift Telecast is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – swifttelecast.com. The content will be deleted within 24 hours.